Melatonin prevents the free radical and MADD metabolic profiles induced by antituberculosis drugs in an animal model

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Pineal Research

• Publication date

  2005-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/j.1600-079X.2004.00176.xPMID 15683464
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Melatonin in humans.

  2006cited by this paper
• Total Antioxidant Levels are Low During Active TB and Rise with Anti‐tuberculosis Therapy

  2004cited by this paper
• Melatonin and mitochondrial function.

  2004cited by this paper
• Regulation of antioxidant enzymes: a significant role for melatonin

  2004cited by this paper
• Acetyl-L-carnitine prevents total body hydroxyl free radical and uric acid production induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the rat.

  2004cited by this paper
• Melatonin: a novel protective agent against oxidative injury of the ischemic/reperfused heart.

  2003cited by this paper
• Safety of 2 months of rifampin and pyrazinamide for treatment of latent tuberculosis.

  2003cited by this paper
• Brief report: melatonin facilitates sleep in individuals with mental retardation and insomnia.

  2003cited by this paper
• The chemistry of melatonin's interaction with reactive species

  2003cited by this paper
• Aromatic Trap Analysis of Free Radicals Production in Experimental Collagen-induced Arthritis in the Rat: Protective Effect of Glycosaminoglycans Treatment

  2003cited by this paper
• Hepatoprotective Activity of Moringa oleifera on Antitubercular Drug-Induced Liver Damage in Rats

  2002cited by this paper
• Melatonin: reducing the toxicity and increasing the efficacy of drugs

  2002cited by this paper
• Reversal of biochemical and behavioral parameters of brain aging by melatonin and acetyl L-carnitine.

  2002cited by this paper
• Glutaric acidemia type II: gene structure and mutations of the electron transfer flavoprotein:ubiquinone oxidoreductase (ETF:QO) gene.

  2002cited by this paper
• Short-Course Rifampin and Pyrazinamide Compared with Isoniazid for Latent Tuberculosis Infection: A Multicenter Clinical Trial

  2002cited by this paper
• Oxidative Stress Increases Susceptibility of Mycobacterium tuberculosis to Isoniazid

  2002cited by this paper
• Acetyl-L-carnitine enhances Na(+), K(+)-ATPase glutathione-S-transferase and multiple unit activity and reduces lipid peroxidation and lipofuscin concentration in aged rat brain regions.

  2001cited by this paper
• Melatonin, mitochondria, and cellular bioenergetics

  2001cited by this paper
• Actions of Melatonin in the Reduction of Oxidative Stress

  2000cited by this paper
• Catalase-peroxidase (Mycobacterium tuberculosis KatG) catalysis and isoniazid activation.

  2000cited by this paper
• Acute isoniazid neurotoxicity during preventive therapy

  2000cited by this paper
• Isoniazid – and rifampicin–induced oxidative hepatic injury – protection by N–acetylcysteine

  2000cited by this paper
• Potentiation of Isoniazid Activity againstMycobacterium tuberculosis by Melatonin

  1999cited by this paper
• Increased serum concentrations of conjugated diens and malondialdehyde in patients with pulmonary tuberculosis.

  1999cited by this paper
• Acute isoniazid intoxication: seizures, acidosis and coma.

  1999cited by this paper
• Free Radicals in Disease

  1998cited by this paper
• Quantification of pyrazinamide and its metabolites in plasma by ionic-pair high-performance liquid chromatography. Implications for the separation mechanism.

  1998cited by this paper
• Free radicals: their history and current status in aging and disease.

  1998cited by this paper
• The role of oxygen free radicals in isoniazid-induced hepatotoxicity.

  1998cited by this paper
• Melatonin in humans.

  1997cited by this paper
• A case of acute deterioration in asthma symptoms induced by isoniazid prophylaxis.

  1997cited by this paper
• Antioxidant actions of melatonin.

  1997cited by this paper
• Determination of pyrazinamide and its main metabolites in rat urine by high-performance liquid chromatography.

  1997cited by this paper
• Study of oxidative-stress in isoniazid-rifampicin induced hepatic injury in young rats.

  1997cited by this paper
• Intentional overdosage with isoniazid: case report and review of literature.

  1996cited by this paper
• Oxidative stress during antituberculous therapy in young and elderly patients.

  1995cited by this paper
• Diseases related to oxygen-derived free radicals.

  1995cited by this paper
• Structure determination of ribosylated rifampicin and its derivative: new inactivated metabolites of rifampicin by mycobacterial strains.

  1995cited by this paper
• Melatonin—A Highly Potent Endogenous Radical Scavenger and Electron Donor: New Aspects of the Oxidation Chemistry of this Indole Accessed in vitro a

  1994cited by this paper
• Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental lewy body disease

  1992cited by this paper
• Newly Identified Forms of Electron Transfer Flavoprotein Deficiency in Two Patients with Glutaric Aciduria Type II

  1991cited by this paper
• Fluorometric Determination of Isoniazid and Its Metabolites in Urine by High‐Performance Liquid Chromatography Using In‐Line Derivatization

  1991cited by this paper
• Hydroxylation of salicylate by microsomal fractions and cytochrome P-450. Lack of production of 2,3-dihydroxybenzoate unless hydroxyl radical formation is permitted.

  1991cited by this paper
• [Oxygen radical production by alveolar macrophages in sarcoidosis in relation to activity status of bronchoalveolar lavage lymphocytes].

  1990cited by this paper
• Correlation between acetylator phenotypes and genotypes of polymorphic arylamine N-acetyltransferase in human liver.

  1990cited by this paper
• The importance of recognizing secondary carnitine deficiency in organic acidaemias: Case report in glutaric acidaemia type II

  1988cited by this paper
• The multiple acyl-coenzyme A dehydrogenation disorders, glutaric aciduria type II and ethylmalonic-adipic aciduria. Mitochondrial fatty acid oxidation, acyl-coenzyme A dehydrogenase, and electron transfer flavoprotein activities in fibroblasts.

  1986cited by this paper
• Deficiency of electron transfer flavoprotein or electron transfer flavoprotein:ubiquinone oxidoreductase in glutaric acidemia type II fibroblasts.

  1985cited by this paper
• Pharmacokinetics of the toxic hydrazino metabolites formed from isoniazid in humans.

  1985cited by this paper
• Multiple acyl-CoA dehydrogenase deficiency: A neonatal onset case responsive to treatment

  1985cited by this paper
• Metabolic effects of carnitine medication in a patient with multiple acyl-CoA dehydrogenation deficiency

  1985cited by this paper
• Oxygen toxicity, oxygen radicals, transition metals and disease.

  1984cited by this paper
• Organic Acids in Man. The Analytical Chemistry, Biochemistry and Diagnosis of the Organic Acidurias

  1983cited by this paper
• Organic Acids in Man

  1983cited by this paper
• Site of action of isoniazid on the electron transport chain and its relationship to nicotinamide adenine dinucleotide regulation in Mycobacterium phlei

  1980cited by this paper
• Quantitative assay of rifampicin and three of its metabolites in human plasma, urine and saliva by high-performance liquid chromatography.

  1978cited by this paper
• Urinary organic acids in man. III. Quantitative ranges and patterns of excretion in a normal population.

  1976cited by this paper
• Urinary excretion of rifampicin and its metabolites as an index of rifampicin blood levels.

  1970cited by this paper
• Urinary excretion of rifampicin and its metabolites as an index of rifampicin blood levels.

  1970cited by this paper
• Severe hypoglycaemia in the course of treatment with streptomycin, isoniazid and ethionamide.

  1967cited by this paper

• Fatal multiple acyl-CoA dehydrogenase deficiency caused by ETFDH gene mutation: A case report

  2024cites this paper
• Urinary markers of Mycobacterium tuberculosis and dysbiosis in paediatric tuberculous meningitis cases undergoing treatment

  2024cites this paper
• Plasma metabolomic and lipidomic alterations associated with anti-tuberculosis drug-induced liver injury

  2022cites this paper
• Metabolomics describes previously unknown toxicity mechanisms of isoniazid and rifampicin.

  2020cites this paper
• The application of metabolomics toward pulmonary tuberculosis research.

  2019cites this paper
• Time-Dependent Changes in Urinary Metabolome Before and After Intensive Phase Tuberculosis Therapy: A Pharmacometabolomics Study

  2019cites this paper
• Synthesis and suggestion of a new nanometric gold(III) melatonin drug complex: an interesting model for testicular protection.

  2018cites this paper
• The role of metabolomics in tuberculosis treatment research.

  2017cites this paper
• Characterising tuberculosis and treatment failure thereof using metabolomics

  2017influential citation
• Metabolomics and Personalized Medicine.

  2016cites this paper
• TB or not TB? Improving the understanding and diagnosis of tuberculosis through metabolomics.

  2016cites this paper
• Tuberculosis metabolomics reveals adaptations of man and microbe in order to outcompete and survive

  2016cites this paper
• A study of the effect of Nigella sativa (Black seeds) on pyrazinamide and anti-tuberculosis drugs induced hepatotoxicity in rabbits.

  2016cites this paper
• Erratum to: Tuberculosis metabolomics reveals adaptations of man and microbe in order to outcompete and survive

  2016cites this paper
• Synthesis of primary amides by aminocarbonylation of aryl/hetero halides using non-gaseous NH3 and CO sources

  2015cites this paper
• Neglected diseases prioritized in Brazil under the perspective of metabolomics: A review

  2015cites this paper
• Vibrational and electronic spectroscopic studies of melatonin.

  2014cites this paper
• Using Metabolomics for Elucidating the Mechanisms Related to Tuberculosis Treatment Failure

  2014influential citation
• Can metabolomics improve tuberculosis diagnostics?

  2014cites this paper
• Characterising tuberculosis treatment success and failure using metabolomics

  2013cites this paper
• New sputum metabolite markers implicating adaptations of the host to Mycobacterium tuberculosis, and vice versa.

  2013cites this paper
• Biomarkers inducing changes due to microwave exposure effect on rat brain

  2011cites this paper
• 900-MHz microwave radiation promotes oxidation in rat brain

  2011cites this paper
• Role of melatonin against oxidative tissue damage induced by Cleistanthus collinus in rat brain.

  2009cites this paper
• Abnormal tricarboxylic acid cycle metabolites in isovaleric acidaemia

  2009cites this paper
• 1800 MHz electromagnetic field effects on melatonin release from isolated pineal glands

  2006cites this paper